Matches in Wikidata for { <http://www.wikidata.org/entity/Q63815791> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q63815791 description "clinical trial" @default.
- Q63815791 description "ensayu clínicu" @default.
- Q63815791 description "klinisch onderzoek" @default.
- Q63815791 description "клінічне випробування" @default.
- Q63815791 name "E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Patients With Hepatocellular Carcinoma" @default.
- Q63815791 type Item @default.
- Q63815791 label "E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Patients With Hepatocellular Carcinoma" @default.
- Q63815791 prefLabel "E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Patients With Hepatocellular Carcinoma" @default.
- Q63815791 P1050 Q63815791-278B6087-9C7E-40E1-B49D-F0B1805E1AE0 @default.
- Q63815791 P1132 Q63815791-BAB3040D-DC44-4CCE-8595-92D7C5C844EE @default.
- Q63815791 P1476 Q63815791-5A8789CE-287E-40E8-9D77-2B07015C5398 @default.
- Q63815791 P17 Q63815791-12D15EBC-1933-4781-9424-51EE3F580E70 @default.
- Q63815791 P17 Q63815791-1EA78E19-172D-4D86-83E5-BBCBA4E68664 @default.
- Q63815791 P17 Q63815791-2BE013EA-1036-45A9-AF8C-FC4EED5DA354 @default.
- Q63815791 P17 Q63815791-4B1288F5-1E4F-4F6F-95E5-E6078FF1CC19 @default.
- Q63815791 P17 Q63815791-AE4F35E0-9004-45F7-9DB3-EF80B7F5DB2D @default.
- Q63815791 P2899 Q63815791-809398E1-A371-476F-BAFD-CA8FCB2CA5ED @default.
- Q63815791 P3098 Q63815791-C2FEEF72-813C-434F-83A4-5F43DE96CB38 @default.
- Q63815791 P31 Q63815791-FB2108A7-5BE0-4753-B5D6-C41427A41BF1 @default.
- Q63815791 P4135 Q63815791-94832662-35C0-4B63-8FCC-FCB0EFEA4070 @default.
- Q63815791 P580 Q63815791-65EEB6FC-BF26-462C-800E-34944FCD42FA @default.
- Q63815791 P582 Q63815791-72F5B6C7-A71A-4959-BD94-F08939409131 @default.
- Q63815791 P6099 Q63815791-73131A2D-BDDF-466E-BEA3-CF9BC620D550 @default.
- Q63815791 P6099 Q63815791-955B002E-031F-4DD0-8AA2-BBF7D68CE914 @default.
- Q63815791 P8363 Q63815791-EFE3CC6A-D811-4C3F-822F-D13116BCBAAB @default.
- Q63815791 P1050 Q33525 @default.
- Q63815791 P1132 "+102" @default.
- Q63815791 P1476 "An Open-Label, Multicenter, Randomized, Phase Ib/II Study of E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Patients With Hepatocellular Carcinoma" @default.
- Q63815791 P17 Q145 @default.
- Q63815791 P17 Q212 @default.
- Q63815791 P17 Q29 @default.
- Q63815791 P17 Q31 @default.
- Q63815791 P17 Q38 @default.
- Q63815791 P2899 "+18" @default.
- Q63815791 P3098 "NCT01271504" @default.
- Q63815791 P31 Q30612 @default.
- Q63815791 P4135 "+99" @default.
- Q63815791 P580 "2011-04-01T00:00:00Z" @default.
- Q63815791 P582 "2015-06-23T00:00:00Z" @default.
- Q63815791 P6099 Q42824440 @default.
- Q63815791 P6099 Q5452194 @default.
- Q63815791 P8363 Q78089383 @default.